|
1
|
Lai NS, Wu DG, Fang XG, Lin YC, Chen SS,
Li ZB and Xu SS: Serum microRNA-210 as a potential noninvasive
biomarker for the diagnosis and prognosis of glioma. Br J Cancer.
112:1241–1246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mansouri A, Mansouri S, Hachem LD,
Klironomos G, Vogelbaum MA, Bernstein M and Zadeh G: The role of
5-aminolevulinic acid in enhancing surgery for high-grade glioma,
its current boundaries, and future perspectives: A systematic
review. Cancer. 122:2469–2478. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Delgado-López PD and Corrales-García EM:
Survival in glioblastoma: A review on the treatment modalities.
Clin Transl Oncol. 18:1062–1071. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mills JD, Chen J, Kim WS, Waters PD,
Prabowo AS, Aronica E, Halliday GM and Janitz M: Long intervening
non-coding RNA 00320 is human brain-specific and highly expressed
in the cortical white matter. Neurogenetics. 16:201–213. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hsiao J, Yuan TY, Tsai MS, Lu CY, Lin YC,
Lee ML, Lin SW, Chang FC, Liu Pimentel H, Olive C, et al:
Upregulation of haploinsufficient gene expression in the brain by
targeting a long non-coding RNA improves seizure phenotype in a
model of dravet syndrome. EBioMedicine. 9:257–277. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Z, Dong M, Fan D, Hou P, Li H, Liu L,
Lin C, Liu J, Su L, Wu L, et al: lncRNA ANCR down-regulation
promotes TGF-β-induced EMT and metastasis in breast cancer.
Oncotarget. 8:67329–67343. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Grzmil M, Morin P Jr, Lino MM, Merlo A,
Frank S, Wang Y, Moncayo G and Hemmings BA: MAP kinase-interacting
kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human
glioblastoma. Cancer Res. 71:2392–2402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang P, Ren Z and Sun P: Overexpression of
the long non-coding RNA MEG3 impairs in vitro glioma cell
proliferation. J Cell Biochem. 113:1868–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu
S, Zhang A, Jia Z, Wang G, Yu S, et al: lncRNA profile of
glioblastoma reveals the potential role of lncRNAs in contributing
to glioblastoma pathogenesis. Int J Oncol. 40:2004–2012.
2012.PubMed/NCBI
|
|
12
|
Zhang XQ, Sun S, Lam KF, Kiang KM, Pu JK,
Ho AS, Lui WM, Fung CF, Wong TS and Leung GK: A long non-coding RNA
signature in glioblastoma multiforme predicts survival. Neurobiol
Dis. 58:123–131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhi F, Wang Q, Xue L, Shao N, Wang R, Deng
D, Wang S, Xia X and Yang Y: The use of three long non-coding RNAs
as potential prognostic indicators of astrocytoma. PLoS One.
10:e01352422015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vital AL, Tabernero MD, Castrillo A,
Rebelo O, Tão H, Gomes F, Nieto AB, Resende Oliveira C, Lopes MC
and Orfao A: Gene expression profiles of human glioblastomas are
associated with both tumor cytogenetics and histopathology. Neuro
Oncol. 12:991–1003. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou J, Xu T, Yan Y, Qin R, Wang H, Zhang
X, Huang Y, Wang Y, Lu Y, Fu D and Chen J: MicroRNA-326 functions
as a tumor suppressor in glioma by targeting the Nin one binding
protein (NOB1). PLoS One. 8:e684692013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang K, Sun X, Zhou X, Han L, Chen L, Shi
Z, Zhang A, Ye M, Wang Q, Liu C, et al: Long non-coding RNA HOTAIR
promotes glioblastoma cell cycle progression in an EZH2 dependent
manner. Oncotarget. 6:537–546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Amit D, Matouk IJ, Lavon I, Birman T,
Galula J, Abu-Lail R, Schneider T, Siegal T, Hochberg A and Fellig
Y: Transcriptional targeting of glioblastoma by diphtheria toxin-A
driven by both H19 and IGF2-P4 promoters. Int J Clin Exp Med.
5:124–135. 2012.PubMed/NCBI
|
|
18
|
Matouk IJ, Mezan S, Mizrahi A, Ohana P,
Abu-Lail R, Fellig Y, Degroot N, Galun E and Hochberg A: The
oncofetal H19 RNA connection: Hypoxia, p53 and cancer. Biochim
Biophys Acta. 1803:443–451. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan C, Jiang Y, Wan Y, Zhang L, Liu J,
Zhou S and Cheng W: Long noncoding RNA NBAT-1 suppresses
tumorigenesis and predicts favorable prognosis in ovarian cancer.
Onco Targets Ther. 10:1993–2002. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pandey GK, Mitra S, Subhash S, Hertwig F,
Kanduri M, Mishra K, Fransson S, Ganeshram A, Mondal T, Bandaru S,
et al: The risk-associated long noncoding RNA NBAT-1 controls
neuroblastoma progression by regulating cell proliferation and
neuronal differentiation. Cancer Cell. 26:722–737. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu P, Chu J, Wu Y, Sun L, Lv X, Zhu Y, Li
J, Guo Q, Gong C, Liu B and Su S: NBAT1 suppresses breast cancer
metastasis by regulating DKK1 via PRC2. Oncotarget. 6:32410–32425.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang C, Wang G, Yang J and Wang L: Long
noncoding RNA NBAT1 negatively modulates growth and metastasis of
osteosarcoma cells through suppression of miR-21. Am J Cancer Res.
7:2009–2019. 2017.PubMed/NCBI
|
|
23
|
Pandey GK and Kanduri C: Fighting
neuroblastomas with NBAT1. Oncoscience. 2:79–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie H, Fu JL and Xie C: miR-138-5p is
downregulated in patients with atrial fibrillation and reverses
cardiac fibrotic remodeling via repressing CYP11B2. Eur Rev Med
Pharmacol Sci. 22:4642–4647. 2018.PubMed/NCBI
|
|
25
|
Zhao X, Sun J, Chen Y, Su W, Shan H, Li Y,
Wang Y, Zheng N, Shan H and Liang H: lncRNA PFAR promotes lung
fibroblast activation and fibrosis by targeting miR-138 to regulate
the YAP1-Twist axis. Mol Ther. 26:2206–2217. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sullivan TB, Robert LC, Teebagy PA, Morgan
SE, Beatty EW, Cicuto BJ, Nowd PK, Rieger-Christ KM and Bryan DJ:
Spatiotemporal microRNA profile in peripheral nerve regeneration:
miR-138 targets vimentin and inhibits Schwann cell migration and
proliferation. Neural Regen Res. 13:1253–1262. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liang Z, Feng Q, Xu L, Li S and Zhou L:
CREPT regulated by miR-138 promotes breast cancer progression.
Biochem Biophys Res Commun. 493:263–269. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao H, Peng R, Liu Q, Liu D, Du P, Yuan
J, Peng G and Liao Y: The lncRNA H19 interacts with miR-140 to
modulate glioma growth by targeting iASPP. Arch Biochem Biophys.
610:1–7. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen L, Wang Y, He J, Zhang C, Chen J and
Shi D: Long non-coding RNA H19 promotes proliferation and invasion
in human glioma cells by downregulating miR-152. Oncol Res. Feb
8–2018.(Epub ahead of print). View Article : Google Scholar
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou W, Ye XL, Xu J, Cao MG, Fang ZY, Li
LY, Guan GH, Liu Q, Qian YH and Xie D: The lncRNA H19 mediates
breast cancer cell plasticity during EMT and MET plasticity by
differentially sponging miR-200b/c and let-7b. Sci Signal.
10:eaak95572017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tang J, Li Y, Sang Y, Yu B, Lv D, Zhang W
and Feng H: LncRNA PVT1 regulates triple-negative breast cancer
through KLF5/beta-catenin signaling. Oncogene. 37:4723–4734. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu HB, Chen Q and Ding SQ: LncRNA
LINC01116 competes with miR-145 for the regulation of ESR1
expression in breast cancer. Eur Rev Med Pharmacol Sci.
22:1987–1993. 2018.PubMed/NCBI
|
|
34
|
Li Q, Gao H, Zhou S and Liao Y: lncRNA
PlncRNA-1 overexpression inhibits the growth of breast cancer by
upregulating TGF-β1 and downregulating PHGDH. Breast Cancer.
25:619–625. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao L, Han T, Li Y, Sun J, Zhang S, Liu
Y, Shan B, Zheng D and Shi J: The lncRNA SNHG5/miR-32 axis
regulates gastric cancer cell proliferation and migration by
targeting KLF4. FASEB J. 31:893–903. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lü MH, Tang B, Zeng S, Hu CJ, Xie R, Wu
YY, Wang SM, He FT and Yang SM: Long noncoding RNA BC032469, a
novel competing endogenous RNA, upregulates hTERT expression by
sponging miR-1207-5p and promotes proliferation in gastric cancer.
Oncogene. 35:3524–3534. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yan J, Zhang Y, She Q, Li X, Peng L, Wang
X, Liu S, Shen X, Zhang W, Dong Y, et al: Long noncoding RNA
H19/miR-675 axis promotes gastric cancer via FADD/Caspase 8/Caspase
3 signaling pathway. Cell Physiol Biochem. 42:2364–2376. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li P, Tong L, Song Y, Sun J, Shi J, Wu Z,
Diao Y, Li Y and Wang Z: Long noncoding RNA H19 participates in
metformin-mediated inhibition of gastric cancer cell invasion. J
Cell Physiol. 234:4515–4527. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bowles J, Schepers G and Koopman P:
Phylogeny of the SOX family of developmental transcription factors
based on sequence and structural indicators. Dev Biol. 227:239–255.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Francois M, Koopman P and Beltrame M: Soxf
genes: Key players in the development of the cardio-vascular
system. Int J Biochem Cell Biol. 42:445–448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Katoh M: Expression of human SOX7 in
normal tissues and tumors. Int J Mol Med. 9:363–368.
2002.PubMed/NCBI
|
|
42
|
Stovall DB, Cao P and Sui G: SOX7: From a
developmental regulator to an emerging tumor suppressor. Histol
Histopathol. 29:439–445. 2014.PubMed/NCBI
|
|
43
|
Chan DW, Mak CS, Leung TH, Chan KK and
Ngan HY: Down-regulation of Sox7 is associated with aberrant
activation of Wnt/b-catenin signaling in endometrial cancer.
Oncotarget. 3:1546–1556. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cui J, Xi H, Cai A, Bian S, Wei B and Chen
L: Decreased expression of Sox7 correlates with the upregulation of
the Wnt/β-catenin signaling pathway and the poor survival of
gastric cancer patients. Int J Mol Med. 34:197–204. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhong WD, Qin GQ, Dai QS, Han ZD, Chen SM,
Ling XH, Fu X, Cai C, Chen JH, Chen XB, et al: SOXs in human
prostate cancer: Implication as progression and prognosis factors.
BMC Cancer. 12:2482012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Stovall DB, Wan M, Miller LD, Cao P,
Maglic D, Zhang Q, Stampfer MR, Liu W, Xu J and Sui G: The
regulation of SOX7 and its tumor suppressive role in breast cancer.
Am J Pathol. 183:1645–1653. 2013. View Article : Google Scholar : PubMed/NCBI
|
